Progression of subclinical cardiovascular disease in patients with HIV
CONCLUSIONS: After six years of follow-up, an increase in SCORE2, carotid plaques, CAC scoring and MESA risk was observed. MDCT findings, along with other clinical and laboratory parameters, could play an important role as a marker of CVD progression in the evaluation of patients with HIV and low cardiovascular risk.PMID:38682819 | DOI:10.37201/req/033.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 29, 2024 Category: Drugs & Pharmacology Authors: M Fayos F Arnaiz de Las Revillas V Gonz ález Quintanilla C Gonz ález-Rico C Fari ñas-Álvarez J A Parra M C Fari ñas Source Type: research
Progression of subclinical cardiovascular disease in patients with HIV
CONCLUSIONS: After six years of follow-up, an increase in SCORE2, carotid plaques, CAC scoring and MESA risk was observed. MDCT findings, along with other clinical and laboratory parameters, could play an important role as a marker of CVD progression in the evaluation of patients with HIV and low cardiovascular risk.PMID:38682819 | DOI:10.37201/req/033.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 29, 2024 Category: Drugs & Pharmacology Authors: M Fayos F Arnaiz de Las Revillas V Gonz ález Quintanilla C Gonz ález-Rico C Fari ñas-Álvarez J A Parra M C Fari ñas Source Type: research
Progression of subclinical cardiovascular disease in patients with HIV
CONCLUSIONS: After six years of follow-up, an increase in SCORE2, carotid plaques, CAC scoring and MESA risk was observed. MDCT findings, along with other clinical and laboratory parameters, could play an important role as a marker of CVD progression in the evaluation of patients with HIV and low cardiovascular risk.PMID:38682819 | DOI:10.37201/req/033.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 29, 2024 Category: Drugs & Pharmacology Authors: M Fayos F Arnaiz de Las Revillas V Gonz ález Quintanilla C Gonz ález-Rico C Fari ñas-Álvarez J A Parra M C Fari ñas Source Type: research
Progression of subclinical cardiovascular disease in patients with HIV
CONCLUSIONS: After six years of follow-up, an increase in SCORE2, carotid plaques, CAC scoring and MESA risk was observed. MDCT findings, along with other clinical and laboratory parameters, could play an important role as a marker of CVD progression in the evaluation of patients with HIV and low cardiovascular risk.PMID:38682819 | DOI:10.37201/req/033.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 29, 2024 Category: Drugs & Pharmacology Authors: M Fayos F Arnaiz de Las Revillas V Gonz ález Quintanilla C Gonz ález-Rico C Fari ñas-Álvarez J A Parra M C Fari ñas Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Glecaprevir/pibrentasvir in combination with ribavirin as salvage therapy in chronic hepatitis C
Rev Esp Quimioter. 2024 Apr 19:sanchez19apr2024. doi: 10.37201/req/020.2024. Online ahead of print.NO ABSTRACTPMID:38638059 | DOI:10.37201/req/020.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 19, 2024 Category: Drugs & Pharmacology Authors: M M S ánchez Suárez A Mart ín Roldán M R Cantudo Cuenca Source Type: research
Septic arthritis due to Pasteurella multocida
Rev Esp Quimioter. 2024 Apr 17:pina17apr2024. doi: 10.37201/req/019.2024. Online ahead of print.NO ABSTRACTPMID:38627987 | DOI:10.37201/req/019.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 17, 2024 Category: Drugs & Pharmacology Authors: C Pi ña Delgado M N Carmona Tello M Bola ños Rivero M C Lavilla Salgado I de Miguel Mart ínez Source Type: research
Septic arthritis due to Pasteurella multocida
Rev Esp Quimioter. 2024 Apr 17:pina17apr2024. doi: 10.37201/req/019.2024. Online ahead of print.NO ABSTRACTPMID:38627987 | DOI:10.37201/req/019.2024 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - April 17, 2024 Category: Drugs & Pharmacology Authors: C Pi ña Delgado M N Carmona Tello M Bola ños Rivero M C Lavilla Salgado I de Miguel Mart ínez Source Type: research
The role of viral diagnostic tests in respiratory tract infections: moving forward
The objective of this panel was to define the plausible role of aetiologic viral diagnostic into clinical management; make recommendations on the potential expanded use of such tests in the future and define some gaps in the management of RTI. Molecular Infection Viral Diagnostic (mIVD) tests should be used in all adult patients admitted to Hospital with RTI, and in paediatric patients requiring admission or who would be referred to another hospital for more specialised care. The increased use of mIVD will not only reduce the inappropriate use of antibiotics so reducing the antibiotic microbe resistance, but also will impr...
Source: Revista Espanola de Quimioterapia - April 12, 2024 Category: Drugs & Pharmacology Authors: R Ort íz de Lejarazu J M Eiros F L ópez-Medrano M Montes A Tagarro M Tom ás Source Type: research
The role of viral diagnostic tests in respiratory tract infections: moving forward
The objective of this panel was to define the plausible role of aetiologic viral diagnostic into clinical management; make recommendations on the potential expanded use of such tests in the future and define some gaps in the management of RTI. Molecular Infection Viral Diagnostic (mIVD) tests should be used in all adult patients admitted to Hospital with RTI, and in paediatric patients requiring admission or who would be referred to another hospital for more specialised care. The increased use of mIVD will not only reduce the inappropriate use of antibiotics so reducing the antibiotic microbe resistance, but also will impr...
Source: Revista Espanola de Quimioterapia - April 12, 2024 Category: Drugs & Pharmacology Authors: R Ort íz de Lejarazu J M Eiros F L ópez-Medrano M Montes A Tagarro M Tom ás Source Type: research
The role of viral diagnostic tests in respiratory tract infections: moving forward
The objective of this panel was to define the plausible role of aetiologic viral diagnostic into clinical management; make recommendations on the potential expanded use of such tests in the future and define some gaps in the management of RTI. Molecular Infection Viral Diagnostic (mIVD) tests should be used in all adult patients admitted to Hospital with RTI, and in paediatric patients requiring admission or who would be referred to another hospital for more specialised care. The increased use of mIVD will not only reduce the inappropriate use of antibiotics so reducing the antibiotic microbe resistance, but also will impr...
Source: Revista Espanola de Quimioterapia - April 12, 2024 Category: Drugs & Pharmacology Authors: R Ort íz de Lejarazu J M Eiros F L ópez-Medrano M Montes A Tagarro M Tom ás Source Type: research
